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Abstract
Introduction Patients with cluster headache (CH), the most common trigeminal autonomic cephalalgia, often face delayed
diagnosis, misdiagnosis and mismanagement.
Objectives To identify, appraise and synthesise clinical studies on the delays in diagnosis and misdiagnosis of CH in order to
determine its causes and help the management of this condition.
Methods The systematic review was prepared, conducted and reported in accordance with the Preferred Reporting Items for
Systematic Review and Meta-Analysis. It was registered with International Prospective Register of Systematic Reviews. A
systematic search of different electronic databases (Medline, EMBASE, PsycINFO, PubMed, CINAHL, BNI, HMIC, AMED,
HBE and Cochrane Library) was carried out in May 2017. Reference lists of relevant articles were hand searched.
Results The search identified 201 unique studies. Fifteen studies met the inclusion criteria of which 13 case series studies and two
survey studies. Nine studies assessed the delays in diagnosis and misdiagnosis of CH, five studies the delays in diagnosis and one
study the misdiagnosis of CH. The studies included 4661 patients. Delays in diagnosis, misdiagnosis and mismanagement have
been reported in many European countries, Japan and in the USA with well-developed health services. The patients with CH
often visited many different clinicians, surgeons and dentists and received multiple diagnosis prior to being correctly diagnosed.
Conclusion This systematic review shows that the delays in the diagnosis of CH are a widespread problem, the time to diagnosis
still vary from country to country and both patients and physicians are responsible for the delays in diagnosis.
Keywords Diagnostic error . Diagnostic mistake . Therapeutic error . Mismanagement . Unrecognised diagnosis
Background
Cluster headache (CH) is the most common of the trigeminal
autonomic cephalalgias (TACs) and often described as the
most severe pain possible [1]. The prevalence of CH is esti-
mated at 0.5–3/1000, with male preponderance [2]. CH is
characterised by attacks of unilateral pain associated with ip-
silateral conjunctival injection, lacrimation, nasal congestion,
rhinorrhoea, forehead and facial sweating, miosis, ptosis and/
or eyelid oedema, and/or with restlessness or agitation [3, 4].
The CH attacks that can last between 15 min and 3 h occur
from every other day to eight times a day [3]. Cluster headache
is maximal orbitally, supraorbitally, temporally or in any com-
bination of these sites, but may spread to other regions [3].
During the worst attacks, the intensity of pain is excruciating.
Patients with CH, unlike those with migraine, are unable to lie
down and characteristically pace and rock back and forth. The
diagnosis of CH is based entirely on clinical history due to the
lack of a diagnostic biomarker. Additionally, CH is uncom-
mon and it is even rarer in the paediatric population, therefore
underrecognised [5]. For these reasons, patients often face
delays in diagnosis and misdiagnosis which inevitably leads
to mismanagement. There have been no rigorous systematic
literature reviews on this topic. The aim of this systematic
literature review is to identify, appraise and synthesise all
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relevant clinical studies on the misdiagnosis and delays in the
diagnosis of CH.
Methods
The systematic review was prepared in accordance with the
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses Protocols (PRISMA-P) 2015 guidelines [6] and was
conducted and reported according to Preferred Reporting
Items for Systematic Reviews and Meta-Analyses
(PRISMA) [7]. It was registered with International
Prospective Register of Systematic Reviews (PROSPERO)
on 9/11/2017 (registration number CRD42017081204).
Search strategy
A comprehensive search of different electronic databases was
carried out in May 2017 to identify potential studies. The
following electronic databases were searched: Medline,
EMBASE, PsycINFO, PubMed, CINAHL, BNI, HMIC,
AMED, HBE (NICE Healthcare Databases) and Cochrane
Library. Pre-specified search criteria were designed with input
from a professional librarian search specialist; Medical
Subject Heading and free text terms were used to increase
the search sensitivity.
To search for misdiagnosis, the search terms were misdiag-
nosis OR diagnostic error OR hidden diagnosis OR
unrecognised diagnosis OR alternate diagnosis OR undiag-
nosed OR diagnostic mistake OR missed diagnosis. The
search terms for delays in diagnosis were delays in diagnosis
OR late diagnosis OR delayed diagnosis. These were com-
bined with a search for cluster headache OR cluster-like head-
ache. In addition to the electronic search, we screened the
reference lists of the included articles and relevant literature
known by the authors. The detailed search criteria are shown
in Table 1.
Two authors (AB and JB) independently assessed all titles
and abstracts for inclusion. The inclusion/exclusion criteria
implemented for all searches are shown in Table 2. Full-text
papers were retrieved for those meeting the inclusion criteria
and for those articles whose eligibility criteria could not be
assessed based only on the title and abstract. Two authors (AB
and JB) independently assessed all full-text articles and dis-
agreement was resolved by discussion to reach consensus and
if needed with the intervention of a third reviewer (FA). The
findings are reported according to PRISMA guidelines [7].
Data extraction, assessment and analysis
The data was independently extracted by two authors (AB and
JB). Data extracted included the study design, methods of data
acquisition, study population (number of participants,
men:women ratio, percentage of patients with episodic cluster
headache (ECH) and chronic cluster headache (CCH)), time
from disease onset to diagnosis (the patient’s delay: the mean
time between the CH attack and first consultation of a clini-
cian, clinician’s delay: the mean time between the first consul-
tation of a clinician and correct diagnosis and the mean total
delay: sum of patient’s delay and clinician’s delay), percentage
of patients misdiagnosed, diagnosis received prior to CH di-
agnosis, the type and number of clinicians seen prior to diag-
nosis, treatment received prior to diagnosis and factors in-
volved in the diagnostic delay. The discrepancies were re-
solved through discussion with a third reviewer (FA).
Risk of bias in individual studies
The risk of bias in individual studies was conducted in order to
assess the quality of the studies included in the SLR. Quality
assessment was performed using the Joanna Briggs Institute
(JBI) Appraisal Checklist for case series studies [8]. Ten do-
mains of the study design and reporting were assessed, each
rated ‘Yes’, ‘No’, ‘Unclear’ or ‘Not applicable’. The Oxford
Centre for Evidence-Based Medicine (OCEBM) critical ap-
praisal was used for survey studies [9]. Ten domains of the
study design and reporting were assessed, each rated ‘Yes’,
‘No’, ‘Unclear’ or ‘Not applicable’. Studies were not excluded
based on their quality appraisal. The studies were indepen-
dently assessed by two reviewers (AB and JB) and the dis-
crepancies were resolved through discussion with a third au-
thor (FA).
Data AvailabilityAll data is fully available without restriction.
Results
Studies included
The search carried out in May 2017 on diagnostic delays
and misdiagnosis of CH identified 201 unique studies
(Fig. 1). The retrieved articles were published between
January 1978 and May 2017. All studies were screened
by title and abstract and 149 articles were excluded at this
stage. Full-text articles were assessed for the remaining 52
studies and 15 studies met our inclusion criteria (Table 2).
Thirty-seven articles were excluded after the full-text
screening; the reasons for exclusion are shown in the
PRISMA flow chart (Fig. 1). The 15 included studies took
place in Europe, the USA and Asia. Four studies were
from the USA, 3 from Denmark and 1 each from
Greece, Serbia, Spain, Norway, Japan, Britain and
Flanders. One study was conducted in multiple countries:
Italy, Moldova, Ukraine and Bulgaria.
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Table 1 Databases and search criteria to identify articles on delays in diagnosis and misdiagnosis of CH
Database Search term Results
1. EMBASE (((cluster ADJ5 headache*).ti,ab OR (cluster - like ADJ5 headache*).ti,ab OR exp “CLUSTER
HEADACHE”/) AND ((misdiagnos*).ti,ab OR (diagnos* ADJ5 error*).ti,ab OR (hid* ADJ5
diagnos*).ti,ab OR (unrecognis* ADJ5 diagnos*).ti,ab OR (alternat* ADJ5 diagnos*).ti,ab OR
(undiagnos*).ti,ab OR (diagnos* ADJ5 mistake*).ti,ab OR (miss* ADJ5 diagnos*).ti,ab OR exp
“MEDICAL ERROR”/ OR exp “DIAGNOSTIC ERROR”/)) OR (((cluster ADJ5 headache*).ti,ab OR
(cluster - like ADJ5 headache*).ti,ab OR exp “CLUSTER HEADACHE”/) AND ((delay* ADJ5
diagnos*).ti,ab OR (late ADJ5 diagnos*).ti,ab OR exp “DELAYED DIAGNOSIS”/))
138
2. PubMed (((cluster ADJ5 headache*).ti,ab OR (cluster - like ADJ5 headache*).ti,ab) AND ((misdiagnos*).ti,ab OR
(diagnos* ADJ5 error*).ti,ab OR (hid* ADJ5 diagnos*).ti,ab OR (unrecognis* ADJ5 diagnos*).ti,ab OR
(alternat* ADJ5 diagnos*).ti,ab OR (undiagnos*).ti,ab OR (diagnos* ADJ5 mistake*).ti,ab OR (miss*
ADJ5 diagnos*).ti,ab)) OR (((cluster ADJ5 headache*).ti,ab OR (cluster - like ADJ5 headache*).ti,ab)
AND ((delay* ADJ5 diagnos*).ti,ab OR (late ADJ5 diagnos*).ti,ab))
104
3. Medline (((cluster ADJ5 headache*).ti,ab OR (cluster - like ADJ5 headache*).ti,ab OR exp “CLUSTER
HEADACHE”/) AND ((misdiagnos*).ti,ab OR (diagnos* ADJ5 error*).ti,ab OR (hid* ADJ5
diagnos*).ti,ab OR (unrecognis* ADJ5 diagnos*).ti,ab OR (alternat* ADJ5 diagnos*).ti,ab OR
(undiagnos*).ti,ab OR (diagnos* ADJ5 mistake*).ti,ab OR (miss* ADJ5 diagnos*).ti,ab OR exp
“MEDICAL ERRORS”/ OR exp “DIAGNOSTIC ERRORS”/)) OR (((cluster ADJ5 headache*).ti,ab
OR (cluster - like ADJ5 headache*).ti,ab OR exp “CLUSTER HEADACHE”/) AND ((delay* ADJ5
diagnos*).ti,ab OR (late ADJ5 diagnos*).ti,ab OR exp “DELAYED DIAGNOSIS”/))
67
4. PsychINFO (((cluster ADJ5 headache*).ti,ab OR (cluster - like ADJ5 headache*).ti,ab) AND ((misdiagnos*).ti,ab OR
(diagnos* ADJ5 error*).ti,ab OR (hid* ADJ5 diagnos*).ti,ab OR (unrecognis* ADJ5 diagnos*).ti,ab OR
(alternat* ADJ5 diagnos*).ti,ab OR (undiagnos*).ti,ab OR (diagnos* ADJ5 mistake*).ti,ab OR (miss*
ADJ5 diagnos*).ti,ab)) OR (((cluster ADJ5 headache*).ti,ab OR (cluster - like ADJ5 headache*).ti,ab)
AND ((delay* ADJ5 diagnos*).ti,ab OR (late ADJ5 diagnos*).ti,ab))
20
5. CINAHL (((cluster ADJ5 headache*).ti,ab OR (cluster - like ADJ5 headache*).ti,ab OR exp “CLUSTER
HEADACHE”/) AND ((misdiagnos*).ti,ab OR (diagnos* ADJ5 error*).ti,ab OR (hid* ADJ5
diagnos*).ti,ab OR (unrecognis* ADJ5 diagnos*).ti,ab OR (alternat* ADJ5 diagnos*).ti,ab OR
(undiagnos*).ti,ab OR (diagnos* ADJ5 mistake*).ti,ab OR (miss* ADJ5 diagnos*).ti,ab OR (delay*
ADJ5 diagnos*).ti,ab OR exp “DIAGNOSTIC ERRORS”/)) OR (((cluster ADJ5 headache*).ti,ab OR
(cluster - like ADJ5 headache*).ti,ab OR exp “CLUSTER HEADACHE”/) AND ((delay* ADJ5
diagnos*).ti,ab OR (late ADJ5 diagnos*).ti,ab OR exp “DIAGNOSIS, DELAYED”/))
20
6. HBE (((cluster ADJ5 headache*).ti,ab OR (cluster - like ADJ5 headache*).ti,ab OR exp “CLUSTER
HEADACHE”/) AND ((misdiagnos*).ti,ab OR (diagnos* ADJ5 error*).ti,ab OR (hid* ADJ5
diagnos*).ti,ab OR (unrecognis* ADJ5 diagnos*).ti,ab OR (alternat* ADJ5 diagnos*).ti,ab OR
(undiagnos*).ti,ab OR (diagnos* ADJ5 mistake*).ti,ab OR (miss* ADJ5 diagnos*).ti,ab OR exp
“DIAGNOSTIC ERRORS”/)) OR (((cluster ADJ5 headache*).ti,ab OR (cluster - like ADJ5
headache*).ti,ab OR exp “CLUSTER HEADACHE”/) AND ((delay* ADJ5 diagnos*).ti,ab OR (late
ADJ5 diagnos*).ti,ab))
1
7. BNI (((cluster ADJ5 headache*).ti,ab OR (cluster - like ADJ5 headache*).ti,ab) AND ((misdiagnos*).ti,ab OR
(diagnos* ADJ5 error*).ti,ab OR (hid* ADJ5 diagnos*).ti,ab OR (unrecognis* ADJ5 diagnos*).ti,ab OR
(alternat* ADJ5 diagnos*).ti,ab OR (undiagnos*).ti,ab OR (diagnos* ADJ5 mistake*).ti,ab OR (miss*
ADJ5 diagnos*).ti,ab)) OR (((cluster ADJ5 headache*).ti,ab OR (cluster - like ADJ5 headache*).ti,ab)
AND ((delay* ADJ5 diagnos*).ti,ab OR (late ADJ5 diagnos*).ti,ab))
1
8. AMED (((cluster ADJ5 headache*).ti,ab OR (cluster - like ADJ5 headache*).ti,ab) AND ((misdiagnos*).ti,ab OR
(diagnos* ADJ5 error*).ti,ab OR (hid* ADJ5 diagnos*).ti,ab OR (unrecognis* ADJ5 diagnos*).ti,ab OR
(alternat* ADJ5 diagnos*).ti,ab OR (undiagnos*).ti,ab OR (diagnos* ADJ5 mistake*).ti,ab OR (miss*
ADJ5 diagnos*).ti,ab)) OR (((cluster ADJ5 headache*).ti,ab OR (cluster - like ADJ5 headache*).ti,ab)
AND ((delay* ADJ5 diagnos*).ti,ab OR (late ADJ5 diagnos*).ti,ab))
0
9. HMIC (((cluster ADJ5 headache*).ti,ab OR (cluster - like ADJ5 headache*).ti,ab) AND ((misdiagnos*).ti,ab OR
(diagnos* ADJ5 error*).ti,ab OR (hid* ADJ5 diagnos*).ti,ab OR (unrecognis* ADJ5 diagnos*).ti,ab OR
(alternat* ADJ5 diagnos*).ti,ab OR (undiagnos*).ti,ab OR (diagnos* ADJ5 mistake*).ti,ab OR (miss*
ADJ5 diagnos*).ti,ab)) OR (((cluster ADJ5 headache*).ti,ab OR (cluster - like ADJ5 headache*).ti,ab)
AND ((delay* ADJ5 diagnos*).ti,ab OR (late ADJ5 diagnos*).ti,ab))
0
10. Cochrane Library #1 cluster near/5 headache*:ti,ab,kw (Word variations have been searched)
#2 cluster-like headache*:ti,ab,kw (Word variations have been searched
#3 MeSH descriptor: (Cluster headache) explode all trees
#4 misdiagnos*
#5 diagnos* near/5 error*
#6 hid* near/5 diagnos*
#7 unrecognis* near/5 diagnos*
#8 alternat* near/5 diagnos*
#9 undiagnos*
1
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Thirteen case series studies and two survey studies
were included. Nine studies assessed the delays in diag-
nosis and misdiagnosis of CH, five studies the delays in
diagnosis and one study the misdiagnosis of CH. The
studies included a total of 4661 patients, aged 3–81 years,
men and women with ECH and CCH. The percentage of
patients with ECH varies from 64 to 100%. The male to
female ratio varied from 1.9:1 [10] to 9.6:1 [11]. One
included study was in children with CH [12]. The data
extracted from case series and survey studies is shown
in Table 3 and Table 4. The values in Tables 3 and 4 are
extracted from the original (referenced) papers and the
percentage values are rounded to the nearest integer. The
number of patients with ECH and CCH was converted
into percentages where necessary for consistency. The ra-
tio (men:women) was calculated if it was not provided in
the cited work.
Non-English articles
Four full-text articles in foreign languages were identified and
translated [13–16]. The articles were excluded as they did not
meet the inclusion criteria (the studies were not on delays in
diagnosis or misdiagnosis of CH).
Risk of bias in individual studies
The 13 case series assessed using JBI Appraisal Checklist
(Table 5) were consecutive case series [11, 12, 17–20] and
non-consecutive case series [21–23] which scored ‘YES’ to
all JBI domains as well as retrospective case series [10, 24]
and one study with unclear inclusion of participants [25]. The
two survey studies were assessed using OCEBM critical ap-
praisal of a survey (Table 6). Using this tool, we identified
studies that did not assess the statistical significance [26, 27]
Table 2 The inclusion and exclusion criteria
Inclusion Exclusion
Study design
Prospective and retrospective studies, case series and survey
studies on misdiagnosis and/or delays in the diagnosis of CH
Case reports
Participants
Children or adult patients with a diagnosis of CH according to
ICHD criteria confirmed by a neurologist
Children or adult patients with a diagnosis of CH not based on ICHD criteria and
not confirmed by a neurologist, studies with less than 10 participants
Date
There will be no restrictions by date
Geographical location
There will be no restrictions by geographical location
Language
There will be no restrictions by language. Non-English language articles will be included and all the foreign language articles will be translated.
However, if the translation is not possible, it will be recorded
Table 1 (continued)
Database Search term Results
#10 diagnos* near/5 mistake*
#11 miss* near/5 diagnos*
#12 MeSH descriptor: (Diagnostic error) explode all trees
#13 delay* near/5 diagnos*
#14 late near/5 diagnos*
#15 MeSH descriptor (Delayed diagnosis) explode all trees
#16 {or #1-#3}
#17 {or #4-#12}
#18 {or #13-#15}
#19 {and #16-#17}
#20 {and #16, #18}
#21 {or #19-#20}
Total number of references 352
Deduplicates removed 154
Total 198
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and did not give the confidence intervals for the main results
[27]. We did not exclude studies based on their quality
appraisal.
Diagnostic delays
Fourteen of the 15 studies investigated the total delay in diag-
nosis (i.e. the time from disease onset to correct diagnosis).
The studies reported different statistics for time to correct di-
agnosis (mean, median or percentage). Ten studies assessed
the mean time to correct diagnosis [10–12, 18–21, 23, 26, 28],
three studies the median time [17, 22, 24] and one study the
percentage of patients that experienced delays in diagnosis
[29]. The mean time to correct diagnosis recorded in the UK
was 2.6 years (between 1990 and 1999) [21], in Flanders
3.6 years [11], in Spain 4.9 years [18], in Italy and East
European countries 5.3 ± 6.4 years [28], in Denmark between
6.2 years [23] and 9 years [20], in the USA between 6.6 [26]
and 8.5 years [12], in Japan 7.3 ± 6.9 years [19] and in Serbia
7.8 ± 8 years (quoted verbatim form the original paper) [10].
The median time to correct diagnosis was 1 year (range 0–7)
in Greece [17], 3 years (range 1–48) in Denmark [22] and
4 years (range 0–30) in Norway [24]. In one study performed
in the USA, 42% of patients waited more than 5 years to
receive a correct diagnosis of cluster headache [29].
Two studies showed a reduction in delay in the diagnosis of
CH over time, from 22.3 years (before 1959) to 2.6 years
(between 1990 and 1999) in the UK [21] and from 20 years
Fig. 1 PRISMA flow diagram of
study selection based on Preferred
Reporting Items for Systematic
Review and Meta-Analysis
Protocols
Neurol Sci
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(prior to 1989) to 1 year (between 2010 and 2015) in Greece
[17]. Two studies looked at patient’s and clinician’s delays in
the diagnosis of CH [11, 28]. Van Alboom et al. showed that
the mean time between the first cluster headache attack and
the first consultation was 11 months [11] and Voiticovski-
Iosob et al. found patient’s delay in almost one quarter of cases
[28].
While Bahra and Goadsby found no significant difference
in time to diagnosis betweenmen and women [21], Lund et al.
showed that men waited amean time of 6.56 years and women
waited 5.5 years [23]. Gender difference was also recorded by
Vikelis and Rapoport where a median of 0 years (range 0–6)
was found for men and 3 years (range 0–7) for women [17].
One study assessed the influence of age of onset on the diag-
nostic delay [10]. Zidverc-Trajkovic et al. showed that the
condition is less recognised in patients with early onset of
CH (less than 20 years of age) [10]. People with late onset
of CH (> 40 years of age) were more rapidly diagnosed than
subjects with typical age of onset of CH (20–40 years of age)
[10]. In the study conducted by Van Vliet et al., the patients
with ECH had longer delays in diagnosis compared to CCH
patients [22], probably due to longer remission periods.
Misdiagnoses prior to correct CH diagnosis
Migraine, trigeminal neuralgia, sinusitis and dental/jaw dis-
ease are the most common misdiagnoses. Other diagnoses
received by the CH patients were tension-type headache; oph-
thalmic disease; ear, nose and throat (ENT) disease; cervical
spine disease; idiopathic intracranial hypertension; allergies;
short lasting neuralgiform headache with conjunctival injec-
tion and tearing (SUNCT) and psychiatric disorders. Migraine
was the most received misdiagnosis [11, 17, 18] followed by
trigeminal neuralgia, [17, 18, 28]. Sinusitis was often diag-
nosed in patients with CH, most likely due to presence of
rhinorrhoea, nasal congestion and seasonal variation, although
there was no significant statistical correlation between these
features and the diagnosis of CH [11]. The mean number of
diagnosis received per patient was 2.2 in Italy and Eastern
Europe [28] and 3.9 in the USA [26]. In Flanders, 65% of
the patients studied were misdiagnosed [11] and in Italy and
East Europe 77% were misdiagnosed [28]. In Denmark, more
women (61%) were misdiagnosed as migraine compared to
men (45.5%) [23].
Clinicians seen prior to correct CH diagnosis
Patients with CHwere often seen by different clinicians before
the correct diagnosis was made. Vikelis and Rapoport showed
that nearly two thirds of their Greek patients (63.5%)
consulted a general practitioner or internist, around one third
an ENT specialist, ophthalmologist or dentist, and a small
proportion (8.5%) a neurosurgeon [17]. In the same study,Ta
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40% of the patients were seen by neurologists who missed the
diagnosis [17]. In Flanders, neurologists correctly diagnosed
80% of cases [11]. Patients often sought help from alternative
medicine specialists (acupuncturists and chiropractors) [11,
24, 25, 28]. Even children consulted many different specialists
prior to diagnosis (internists, general practitioners, otolaryn-
gologists, opthalmologists, psychiatrists, chiropractors, ortho-
paedic surgeons and allergists) [12]. Self-diagnosis using dif-
ferent sources of information (internet, reading about CH and
discussion with other people suffering with CH) with subse-
quent medical confirmation was the second most common
way of diagnosis after clinician’s diagnosis [17] and it was
reported in 4%, 13% and 15% of patients in Flanders [11],
the UK [21] and Italy and East European countries respective-
ly [28]. Patients consulted between 2 and 5 clinicians before
the correct diagnosis was made [11, 17, 18, 28] frequently
including a dentist, ENT specialists or ophthalmologist who
exceptionally made the diagnosis [11]. Vikelis and Rapoport
found that patients with CCH consulted more clinicians than
patients with ECH (median 4 vs 2) [17] and no differences in
the number of clinicians consulted by men and women were
found [17]. Most patients with CH have never been seen by
specialists in emergency medicine [29]. The most obvious
explanation would be the short duration of the attacks.
Mismanagement prior to correct CH diagnosis
General neurologists frequently offered non-evidence-based
CH treatments [12, 17, 28]. Dentists and ENT specialists per-
formed tooth extractions, fillings, sinus washout and surgery
for nasal septum deviation without any success. Dentists, ENT
specialists or other clinicians that did not recognise the disor-
der often recommend unnecessary investigations (MRI head,
CT head, EEC, cervical spine X-ray, skull X-ray) to diagnose
a secondary headache [28]. Patients underwent alternative
medicine treatments such as acupuncture [11, 24, 25, 27],
homoeotherapy [28], chirotherapy [24, 25, 28], relaxation
techniques [28], cold therapy [28], reflexology [11], hypnosis
[11], osteopathy [11], spiritual healing [11] and illicit drug use
[24, 28]. Even after correct diagnosis of CH, the patients
complained of lack of information regarding the cause of the
disorder and available treatments [18]. Some patients received
incorrect information as to the cause of CH (psychiatric, vas-
cular disorder, genetic/familial, brain injury, alcohol, tobacco)
and others no information [18].
Factors involved in the diagnostic delay
and misdiagnosis
Three studies assessed the factors involved in the diagnostic
delay [11, 17, 22]. Van Vliet et al. showed that the presence of
ECH, nausea, vomiting during attacks, photophobia or
phonophobia, nocturnal onset of attacks, restlessness, pain
radiating to the jaw, alternating attack side and circadian
rhythm delayed the diagnosis of CH [22]. The male gender
and interictal headache did not influence the correct diagnosis
of CH [22]. However, Vikelis and Rapoport showed that the
side shift between bouts, jaw location of pain, the cheek loca-
tion of pain, lower teeth location of pain, ear location of pain,
aggravation by physical activity, the presence of forehead and
facial sweating, the presence of photophobia and the absence
of cranial autonomic features delayed the correct diagnosis of
CH [17]. The authors have also shown that the decade of onset
of CH influenced the correct diagnosis [17]. Patients with
onset before the year 2000 waited a median of 13 years (range
0–45) to be diagnosed compared to patients with onset after
the year 2010 who waited a median of 1 year (range 1–7) [17].
A lower age of onset and pain that does not reach the maxi-
mum intensity within the first 5 min were also features that
contributed to diagnostic delay [11].
Discussion
It is evident from the studies that diagnostic delay in CH is not
confined to a geographical area. Although some countries had
less delay than others, delays in diagnosis were recorded in
multiple countries in Europe, the USA and Japan. One possi-
ble reason could be limited knowledge about the characteris-
tics of CH across countries. However, these results should be
interpreted with caution as each study does not reflect the
whole CH population of a country. Only one nationwide sur-
vey study performed in the USA that included a sample of
1134 patients was retrieved by our searches and could be
considered representative for a large cohort of patients with
CH [29]. The studies were performed over a period of 25 years
and are not directly comparable as the International
Classification of Headache Disorders has suffered amend-
ments over the years.
The studies included in this review showed that patient’s
delay in diagnosis is as important as clinician’s delay [11, 28].
The reason why patients with CH do not seek timely medical
advice is not well understood. The short duration of the attacks
could be an explanation although there are currently no studies
that assessed this.
It has been shown that the episodic pattern of attacks, a
specific feature of CH, does not seem to contribute to an
earlier diagnosis [22]. Moreover, extended periods of remis-
sions only prolong the diagnostic delay. Improved awareness
of the condition is the most probable reason for the reduction
of time to correct diagnosis in the UK, Greece and Denmark
[17, 20, 21, 23]. It is unclear why patients with late onset CH
were more rapidly diagnosed than those with early onset [10].
It is possible that clinicians erroneously view CH as a disorder
with onset predominantly in late adulthood. Another explana-
tion might be that clinicians are more suspicious of a sinister
Neurol Sci
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cause for the symptoms if the patient is older, and therefore
have a lower threshold to refer to a neurologist although there
are no studies that have assessed this.
A lack of knowledge of the characteristics of CH is
likely to influence the clinician to seek an alternative di-
agnosis. Some CH characteristics could lead the clinician
astray. For example, migraine features (e.g. aura, photo-
phobia, phonophobia, nausea, vomiting) and a family his-
tory of migraine are often encountered in patients with
CH [22]. The features of the pain in CH may also mislead
the clinician in making the wrong diagnosis. Although
CH affects the first division of the trigeminal nerve while
trigeminal neuralgia the second or third and exceptionally
the first division, trigeminal neuralgia was the second
most received misdiagnosis in two studies [17, 18]. The
presence of stereotyped attacks associated with cranial
autonomic symptoms, the absence of triggers and the to-
tally different duration and pain quality still qualify tri-
geminal neuralgia as one of the most received misdiagno-
sis [17, 18, 28]. It is possible that clinicians are more
aware of trigeminal neuralgia, even though CH is more
common (incidence 53/100.000 [30] vs 4.5/100.00 [31])
but there are no studies that validated this. The presence
of side shift between attacks was also correlated with di-
agnostic delay possibly because CH is defined as ‘unilat-
eral pain’ as per ICHD-3 criteria [3].
Misdiagnosis invariably leads to mismanagement. In
CH, due to the severity of the symptoms, patients desper-
ately seek the opinion of several specialists until the
symptoms are alleviated. It is possible that some special-
ists feel the need to offer invasive procedures in an at-
tempt to provide some form of relief, even if the chance
of success is small. A high proportion of patients with CH
undergo invasive procedures from dental surgeons and
ENT specialists when a clear indication for such interven-
tions was lacking. These results suggest that further
awareness is required, particularly in the dental and ENT
professions regarding the pain and cranial autonomic
symptoms of CH mimicking dental and sinus pathologies,
to avoid unnecessary and potentially harmful procedures.
In an attempt to treat their symptoms, patients with CH are
more likely to employ extreme measures. The use of illicit
drugs among CH sufferers is common [24, 28]. They are also
more inclined to have recourse to non-evidence-based and
non-pharmocological treatments [11, 24]. This further sup-
ports the need for timely diagnosis and initiation of
evidence-based treatments, and patient education. The evi-
dence suggests that even after the correct diagnosis is reached,
some patients received poor or incorrect information about the
nature of their disability [18]. Suboptimal management is not
limited to the cluster headache sufferers since most headache
patients are undertreated, hence the importance of headache
centres and promoting education of GPs [32].Ta
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Strengths
This is the first rigorously conducted systematic review on
delays in diagnosis and misdiagnosis of cluster headache. A
detailed search strategy of 10 electronic databases was used
with no date or language restrictions. We included larger stud-
ies that could demonstrate rigorous analysis and we have ex-
cluded studies with less than 10 patients and case reports.
Limitations
It is possible that relevant studies were missed despite a com-
prehensive search strategy across multiple databases with no
date or language restrictions. Due to the paucity of studies in
this area, we did not exclude studies on the basis of quality
appraisal.
Future work
As CH is a life-long severe and debilitating condition that
requires prompt diagnosis and management, it is essential to
establish what factors are involved in the diagnostic delay and
misdiagnosis. Educational activities for general practitioners,
ENT specialists, ophthalmologists and other medical special-
ities and even for neurologists are important to raise awareness
of CH, its diagnosis and management. Getting medical and
emotional support are important priorities for CH sufferers.
Clinicians of all specialities should be aware of the existence
of CH and long-term support should be in place so that pa-
tients with CH can live a normal life. Future work regarding
biomarkers could help in the misdiagnosis and delays in the
diagnosis of CH.
Conclusions
Delays in diagnosis, misdiagnosis and mismanagement of CH
are a widespread problem and have been reported in many
countries with well-developed health services, including sev-
eral European countries, Japan and in the USA. Both patient
and clinician factors account for the delays in diagnosis.
Patients with CH often waited before seeking medical advice
and when they did, they visited many clinicians and received
multiple misdiagnosis prior to being correctly diagnosed. The
failure to diagnose patients with CH leads to poor manage-
ment, disability and misuse of healthcare resources. If a clini-
cian has a suspicion of CH, this should trigger referral to
specialised headaches centres for a correct diagnosis and ini-
tiation of appropriate treatment and tominimise the wastage of
healthcare resources and unnecessary procedures.
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